US Patent Issued to Gilead Sciences on Sept. 9 for "Processes and intermediates for preparing MCL1 inhibitors" (American, Canadian, British Inventors)

Posted On: 2025-09-10

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,146, issued on Sept. 9, was assigned to Gilead Sciences Inc. (Foster City, Calif.).

"Processes and intermediates for preparing MCL1 inhibitors" was invented by Katrien Brak (Belmont, Calif.), Kae M. Bullock (San Carlos, Calif.), Greg Cizio (San Mateo, Calif.), Kathy Dao (San Mateo, Calif.), Darryl D. Dixon (San Mateo, Calif.), Joshua R. Dunetz (Burlingame, Calif.), Luke D. Humphreys (Shropshire, Great Britain), Valerie Huynh (Santa Clara, Calif.), Michael A. Ischay (San Mateo, Calif.), Trevor C. Johnson (San Mateo, Calif.), Jeffrey E. Merit (San Mateo, Calif.), Christopher S. Regens (San Francisco), Eric A. Standley (Foster City, Calif.), Dietrich P. Steinhuebel (Cambridge, Mass....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

US Patent Issued to Gilead Sciences on Sept. 9 for "Processes and intermediates for preparing MCL1 inhibitors" (American, Canadian, British Inventors)